Back to Search Start Over

The fecal mycobiome in non-alcoholic fatty liver disease.

Authors :
UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - (SLuc) Service de gastro-entérologie
Demir, Münevver
Lang, Sonja
Hartmann, Phillipp
Duan, Yi
Martin, Anna
Miyamoto, Yukiko
Bondareva, Marina
Zhang, Xinlian
Wang, Yanhan
Kasper, Philipp
Bang, Corinna
Roderburg, Christoph
Tacke, Frank
Steffen, Hans-Michael
Goeser, Tobias
Kruglov, Andrey
Eckmann, Lars
Stärkel, Peter
Fouts, Derrick E
Schnabl, Bernd
UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - (SLuc) Service de gastro-entérologie
Demir, Münevver
Lang, Sonja
Hartmann, Phillipp
Duan, Yi
Martin, Anna
Miyamoto, Yukiko
Bondareva, Marina
Zhang, Xinlian
Wang, Yanhan
Kasper, Philipp
Bang, Corinna
Roderburg, Christoph
Tacke, Frank
Steffen, Hans-Michael
Goeser, Tobias
Kruglov, Andrey
Eckmann, Lars
Stärkel, Peter
Fouts, Derrick E
Schnabl, Bernd
Source :
Journal of hepatology, Vol. 76, no.4, p. 788-799 (2022)
Publication Year :
2022

Abstract

Studies investigating the gut-liver axis have largely focused on bacteria, whereas little is known about commensal fungi. We characterized fecal fungi in patients with non-alcoholic fatty liver disease (NAFLD) and investigated their role in a fecal microbiome-humanized mouse model of Western diet-induced steatohepatitis. We performed fungal internal transcribed spacer 2 sequencing using fecal samples from 78 patients with NAFLD, 16 controls and 73 patients with alcohol use disorder. Anti-Candida albicans (C. albicans) IgG was measured in blood samples from 17 controls and 79 patients with NAFLD. Songbird, a novel multinominal regression tool, was used to investigate mycobiome changes. Germ-free mice were colonized with feces from patients with non-alcoholic steatohepatitis (NASH), fed a Western diet for 20 weeks and treated with the antifungal amphotericin B. The presence of non-obese NASH or F2-F4 fibrosis was associated with a distinct fecal mycobiome signature. Changes were characterized by an increased log-ratio for Mucor sp./Saccharomyces cerevisiae (S. cerevisiae) in patients with NASH and F2-F4 fibrosis. The C. albicans/S. cerevisiae log-ratio was significantly higher in non-obese patients with NASH when compared with non-obese patients with NAFL or controls. We observed a different fecal mycobiome composition in patients with NAFLD and advanced fibrosis compared to those with alcohol use disorder and advanced fibrosis. Plasma anti-C. albicans IgG was increased in patients with NAFLD and advanced fibrosis. Gnotobiotic mice, colonized with human NASH feces and treated with amphotericin B were protected from Western diet-induced steatohepatitis. Non-obese patients with NAFLD and more advanced disease have a different fecal mycobiome composition to those with mild disease. Antifungal treatment ameliorates diet-induced steatohepatitis in mice. Intestinal fungi could be an attractive target to attenuate NASH. Non-alcoholic fatty liver disease is one of the most co

Details

Database :
OAIster
Journal :
Journal of hepatology, Vol. 76, no.4, p. 788-799 (2022)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1372953103
Document Type :
Electronic Resource